LeonaBio LONA
NASDAQ LONA
$4.38 +0.81 (+22.72%)
As of: Oct 1, 2026 · 3:59 PM EDT

LeonaBio (LONA) Other Non-Current Liabilities (2019 - 2026)

Updated

LeonaBio (LONA) reported Other Non-Current Liabilities of $1.03 million for Q2 2026, down 15.3% from the prior quarter.

Analysis

LeonaBio (LONA) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, LeonaBio posted Other Non-Current Liabilities of $1.4 million.

  • The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 LeonaBio 84.70 Mn -147.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 1.22 Mn
Dec 31, 2025 1.40 Mn
Dec 31, 2019 999,000.00
API Access

LeonaBio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LONA&period=max&api_key=YOUR_API_KEY